Tuesday, August 03, 2021 8:31:20 AM
ABSI
New York Yankees and Duke Basketball
Recent ABSI News
- Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 05/28/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 11:35:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:32:37 AM
- Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024 • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 03/01/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:06:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/28/2024 01:34:42 PM
- Absci Announces Pricing of Public Offering of Common Stock • GlobeNewswire Inc. • 02/28/2024 03:20:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:45:04 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/27/2024 09:40:17 PM
- Absci Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 02/27/2024 09:01:00 PM
- Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI • GlobeNewswire Inc. • 02/21/2024 12:30:00 PM
- Absci to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/20/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/13/2024 11:16:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:14:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:14:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:12:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 12:09:28 AM
- Absci Appoints Professor Sir Mene Pangalos to its Board of Directors • GlobeNewswire Inc. • 01/10/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:08:52 PM
- Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/08/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:58:34 PM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM